S&P 500: 669.03 +1.0% NASDAQ 100: 600.38 +1.1% Dow Jones: 470.30 +0.8%

Jeremy Grantham’s CVS Holdings & Trades

First Buy
Q2 2013
Duration Held
41 Quarters
Largest Add
Q2 2013
+2.31 M Shares
Current Position
721,118 Shares
$57.23 M Value

Jeremy Grantham's CVS Position Overview

Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 721,118 shares of CVS Health Corporation (CVS) worth $57.23 M, representing 0.15% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 41 quarters.

Based on 13F filings since 2013, Jeremy Grantham has maintained a long-term strategic position in CVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2015, adding 1.01 M shares. Largest reduction occurred in Q1 2014, reducing 1.7 M shares.

Analysis based on 13F filings available since 2013 Q2

Jeremy Grantham's CVS Health Corporation (CVS) Holding Value Over Time

Track share changes against reported price movement

Quarterly CVS Health Corporation (CVS) Trades by Jeremy Grantham

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 -39,834 Reduce 5.23% 721,118 $79.36
Q3 2025 -91,273 Reduce 10.71% 760,952 $75.39
Q2 2025 -89,142 Reduce 9.47% 852,225 $68.98
Q1 2025 +165,572 Add 21.34% 941,367 $67.75
Q4 2024 -118,525 Reduce 13.25% 775,795 $44.89
Q3 2024 +4,547 Add 0.51% 894,320 $62.88
Q2 2024 +173,083 Add 24.15% 889,773 $59.06
Q1 2024 -65,702 Reduce 8.40% 716,690 $79.76
Q4 2023 -55,527 Reduce 6.63% 782,392 $78.96
Q3 2023 +36,827 Add 4.60% 837,919 $69.82
Q2 2023 +71,404 Add 9.79% 801,092 $69.13
Q1 2023 +199,400 Add 37.60% 729,688 $74.31
Q4 2022 +158,588 Add 42.67% 530,288 $93.19
Q3 2022 +47,000 Add 14.47% 371,700 $95.37
Q2 2022 +83,900 Add 34.84% 324,700 $92.66
Q1 2022 -61,800 Reduce 20.42% 240,800 $101.21
Q4 2021 -81,200 Reduce 21.16% 302,600 $103.16
Q3 2021 +17,900 Add 4.89% 383,800 $84.86
Q2 2021 +50,768 Add 16.11% 365,900 $83.44
Q1 2021 +75,632 Add 31.58% 315,132 $75.23
Q4 2020 +239,500 New Buy 239,500 $68.30
Q1 2018 -1.06 M Sold Out 0 $0.00
Q4 2017 -6,700 Reduce 0.63% 1.06 M $72.50
Q3 2017 -67,589 Reduce 5.97% 1.07 M $81.32
Q2 2017 +29,310 Add 2.66% 1.13 M $80.46
Q1 2017 -37,428 Reduce 3.28% 1.1 M $78.50
Q4 2016 -3,764 Reduce 0.33% 1.14 M $78.91
Q3 2016 -681,481 Reduce 37.32% 1.14 M $88.99
Q2 2016 -493,133 Reduce 21.26% 1.83 M $95.74
Q1 2016 +18,099 Add 0.79% 2.32 M $103.73
Q4 2015 -96,900 Reduce 4.04% 2.3 M $97.77
Q3 2015 +339,172 Add 16.47% 2.4 M $96.48
Q2 2015 +1.01 M Add 96.25% 2.06 M $104.88
Q1 2015 +822,725 Add 363.56% 1.05 M $103.21
Q4 2014 -121,500 Reduce 34.93% 226,300 $96.31
Q3 2014 +238,700 Add 218.79% 347,800 $79.59
Q2 2014 -1.54 M Reduce 93.38% 109,100 $75.37
Q1 2014 -1.7 M Reduce 50.71% 1.65 M $74.86
Q4 2013 +442,526 Add 15.24% 3.35 M $71.57
Q3 2013 +595,854 Add 25.83% 2.9 M $56.75
Q2 2013 +2.31 M Add 0.00% 2.31 M $57.18

Jeremy Grantham's CVS Health Corporation Investment FAQs

Jeremy Grantham first purchased CVS Health Corporation (CVS) in Q2 2013, acquiring 2,306,974 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jeremy Grantham has held CVS Health Corporation (CVS) for 41 quarters since Q2 2013.

Jeremy Grantham's largest addition to CVS Health Corporation (CVS) was in Q2 2013, adding 2,306,974 shares worth $131.91 M.

According to the latest 13F filing for Q4 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 721,118 shares of CVS Health Corporation (CVS), valued at approximately $57.23 M.

As of the Q4 2025 filing, CVS Health Corporation (CVS) represents approximately 0.15% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.

Jeremy Grantham's peak holding in CVS Health Corporation (CVS) was 3,345,354 shares, as reported at the end of Q4 2013.